As I've said and continue to say, shorts are having their last dance. Then the party's over.
First, JG is "informally' associated with the company. He is not on the payroll. I might add that his "reactionary" opinions are shared by many of us living here in Israel and who are frustrated with the tripe we see expressed in op-ed pieces in the New York Times, the rag from which he culls and then critiques content. I find his work quite erudite and a fine antidote to the prevailing stupidity. JMO.
Besides, labels like "reactionary" are rather vacuous--don't you think?
Recent announcement re:Japan's new law includes statement saying, ""As a result of Japan's favorable new law, cell therapies like Pluristem's PLX cells can receive market approval in Japan upon completion of Phase II trials when good safety and efficacy data is available. This could potentially reduce approval time down to two or three years..."
Which trials and for which indication? Are these trials in progress or something just beginning? I assume the latter because a more specific trial and indication would have been explicit. My assumption is more a guess.
I don't think anyone has such a misguided expectation of guaranteed returns. But it seems illogical for the stock to behave as it's done for last couple of years. Despite the fact that I believe the high short interest and mega-manipulation is in the process of subsiding, it is frustrating especially given the potential so many longs recognize. I've made good returns with this stock in 2012 and expect to again. The wait has taken much longer than I expected but the expectation is still long and strong.
There's been very high short interest for some time, part of which likely attributed to the former CEO who passed away a couple months ago. Now that legal issues have been resolved with his death and improvements begun under new management over the past year and a half are taking shape, the short interest will very likely fall dramatically over the weeks to come. The protracted period of manipulation is waning and shorts are covering. You are correct that the financials indicate the stock is highly undervalued but that won't be for long, in my opinion.
Please share the "bloated expense sheet"---the one with "no sales results." Please also make available the evidence that, since the last cc, the "subscribers are falling," Also, can you please verify the statement that there are no "Go" models in Targets or RIte Aids because they "can't get into these stores." I'm waiting........
I don't think that intermittent announcements from company would alter the stock price trajectory at this point. I am long and strong and believe the shorts are doing their farewell cover-dance. I don't think the manipulation will last much past the next earnings report.
Since my last post, I've learned that short interest is reduced another 400,000 shares, so I continue to believe that shorts are on process to cover and bid a fond farewell to CALL.
For what it's worth, my theory is this.....shorts know that the company will perform. This is likely the last coordinated effort to force the price down so the bulk of the remaining shorts can cover luxuriously. I suspect that, in 4-6 weeks, the worst will be over and the short numbers will be dramatically lower and the price action will no longer be so volatile.
Adding MJ would be a great addition to such a move by Telefonica, if it happens. They'd be in a very strong position.
You remind me of the 5 Hamas operatives who blew themselves up when an incendiary device they were building blew up by accident. POW! Sweet!